subject: PUBCHEM.COMPOUND:21879648


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: Other nonspecific abnormal serum enzyme levels

tested_intervention: unsure


subject: UNII:490D9F069T

subject_name: Lanthanum carbonate tetrahydrate


subject: UNII:0M78EU4V9H

subject_name: Lanthanum carbonate


subject: UNII:P7186074QC

subject_name: Rozanolixizumab

object_name: myelin oligodendrocyte glycoprotein antibody-associated disease

tested_intervention: yes


subject: UMLS:C0063355

subject_name: IgY

object_name: cystic fibrosis


subject: PUBCHEM.COMPOUND:27991

subject_name: dAVP

object_name: Bedwetting


subject: PUBCHEM.COMPOUND:27991

object_name: sickle cell disease


subject: PUBCHEM.COMPOUND:16051933

subject_name: DESMOPRESSIN


subject: PUBCHEM.COMPOUND:16051933


subject: UNII:QD4VI0J9T5

subject_name: Centhaquine

object_name: Hypovolemic shock


subject: UNII:QD4VI0J9T5

object_name: Blood Loss


subject: UNII:QD4VI0J9T5

object_name: Hemorrhage


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin

object_name: Cirrhosis


subject: UNII:8NZ41MIK1O

object_name: liver cirrhosis


subject: UNII:VVA2ZDV3LX


subject: UMLS:C1135137

object_name: Neck Carcinoma


subject: UMLS:C1135137

object_name: head and neck neoplasm


subject: UMLS:C1135137

object_name: head and neck cancer


subject: UMLS:C1541530

object_name: leukemia


subject: UMLS:C1541530

object_name: childhood leukemia


subject: UMLS:C1541530

object_name: acute graft versus host disease


subject: UMLS:C4721962

object_name: diabetic neuropathy


subject: CHEBI:71013

subject_name: Perampanel


subject: CHEBI:49668

subject_name: Gefitinib

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: schizophrenia


subject: PUBCHEM.COMPOUND:54675783

object_name: schizoaffective disorder


subject: PUBCHEM.COMPOUND:54675783

object_name: schizophrenia 18


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: mucopolysaccharidosis type 1


subject: UNII:NQX9KB6PCL

object_name: Hunter Syndrome


subject: UNII:NQX9KB6PCL

object_name: mucopolysaccharidosis type 6


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0169964


subject: UMLS:C0169964


subject: CHEBI:64312

subject_name: Memantine

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:64312

object_name: amyotrophic lateral sclerosis


subject: UMLS:C1563959

subject_name: Ebixa


subject: UMLS:C1563959


subject: CHEBI:34954

subject_name: (S)-ropivacaine hydrochloride hydrate

object_name: Post-Operative Pain


subject: CHEBI:141427

subject_name: Asp-Thr

object_name: Transfusion dependent thalassaemia


subject: UMLS:C0086126


subject: UMLS:C2984509

subject_name: Diphtheria Toxoid/Tetanus Toxoid Vaccine Adsorbed


subject: CHEBI:17748

subject_name: Thymidine


subject: CHEBI:4728

subject_name: Dyphylline


subject: PR:000031275

subject_name: dystonin


subject: PR:000006321

subject_name: L-dopachrome tautomerase


subject: UMLS:C5785436

subject_name: Lutetium Lu 177 Ludotadipep

object_name: Metastatic castration-resistant prostate cancer


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: HIV infection


subject: CHEBI:45716

subject_name: Vorinostat

object_name: leukemia


subject: CHEBI:45716

object_name: childhood leukemia


subject: CHEMBL.COMPOUND:CHEMBL2107910

subject_name: OLIVE OIL

object_name: type 2 diabetes mellitus


subject: CHEBI:230791

subject_name: tributyrylglycerol


subject: CHEBI:35020

subject_name: Tributyrin


subject: CHEBI:74824

subject_name: Thr-Ala

object_name: myoma


subject: PUBCHEM.COMPOUND:4532223

subject_name: Tantalum


subject: PR:000006886

subject_name: ectodysplasin-A


subject: PR:000016550


subject: CHEBI:16704

subject_name: Uridine

object_name: bipolar disorder


subject: CHEBI:16704

object_name: bipolar depression


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Stiff knee gait


subject: CHEBI:3160

object_name: brain injury


subject: UMLS:C4534650

subject_name: Mepsevii

object_name: Sly Syndrome


subject: CHEBI:35812

subject_name: Oxfendazole

object_name: trichuriasis


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: small cell lung carcinoma


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: prostate carcinoma


subject: CHEBI:192614

object_name: prostate cancer


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: CHEBI:94708

subject_name: Diacerein

object_name: Overweight


subject: CHEBI:94708

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:94708

object_name: obesity


subject: CHEBI:94708

object_name: Obesity, CTCAE


subject: UMLS:C5418074

subject_name: ADC MRG002

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:TUK9QB44B0

object_name: Primary malignant neoplasm


subject: UNII:TUK9QB44B0

object_name: childhood malignant neoplasm


subject: UNII:TUK9QB44B0

object_name: Malignant obstetric neoplasm


subject: UMLS:C5392518


subject: UMLS:C5392518


subject: UMLS:C5392518


subject: DRUGBANK:DB16497

object_name: bronchiectasis


subject: DRUGBANK:DB16497

object_name: Chronic obstructive pulmonary disease of horses


subject: DRUGBANK:DB16497

object_name: COPD, severe early onset


subject: DRUGBANK:DB16497

object_name: chronic obstructive pulmonary disease


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Stage IIIC Cutaneous Melanoma AJCC v7


subject: CHEBI:8499

subject_name: Propranolol


subject: CHEBI:8499

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones

object_name: alcoholic hepatitis


subject: CHEBI:221840

object_name: unspecified adult solid tumor, protocol specific


subject: PUBCHEM.COMPOUND:4616292


subject: CHEBI:50005

subject_name: trans-stilbene oxide

object_name: autism spectrum disorder


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: Childhood Solid Neoplasm


subject: GTOPDB:9758

object_name: Adult Solid Neoplasm


subject: GTOPDB:9758

object_name: Solid Neoplasm


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UNII:768FW21J3L

subject_name: Famitinib


subject: UNII:768FW21J3L


subject: UNII:768FW21J3L


subject: PUBCHEM.COMPOUND:11654566

subject_name: Idelalisib

object_name: follicular lymphoma


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: UMLS:C5882209

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C5882209

object_name: obesity


subject: UMLS:C5882209

object_name: Obesity, CTCAE


subject: UMLS:C5882209

object_name: Overweight


subject: UNII:41T4OAG59U

subject_name: Aleglitazar

object_name: type 2 diabetes mellitus


subject: UNII:41T4OAG59U

object_name: maturity-onset diabetes of the young type 1


subject: UMLS:C2348244

subject_name: aleglitazar


subject: UMLS:C2348244


subject: CHEBI:6801

subject_name: Metformin


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: carcinoid syndrome


subject: CHEBI:6427

subject_name: Leuprolide

object_name: amenorrhea


subject: CHEBI:6427

object_name: Amenorrhea, CTCAE


subject: CHEBI:6427

object_name: Ovarian function insufficiency


subject: CHEBI:6427

object_name: primary ovarian failure


subject: CHEBI:6427

object_name: premature menopause


subject: UNII:02DZ1HBF0M

subject_name: Emixustat

object_name: Anetoderma


subject: CHEBI:166520

subject_name: Tenamfetamine

object_name: post-traumatic stress disorder


subject: CHEBI:166520

object_name: BH4-deficient hyperphenylalaninemia A


subject: CHEBI:166520

object_name: Relationship problems (finding)


subject: CHEBI:1391

subject_name: Midomafetamine


subject: CHEBI:1391


subject: CHEBI:1391


subject: CHEBI:9123

subject_name: Sertraline

object_name: generalized anxiety disorder


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: UMLS:C2348288

subject_name: Dietary Zinc


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:27363

subject_name: Zinc


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: CHEBI:29708

subject_name: Zinc gluconate


subject: CHEBI:33198

subject_name: Gluconic Acid


subject: PUBCHEM.COMPOUND:23664049

subject_name: SODIUM GLUCONATE


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b

object_name: renal cell carcinoma


subject: UMLS:C4553183

subject_name: Androgen Receptor Inhibitor

object_name: prostate carcinoma


subject: UMLS:C4553183

object_name: prostate cancer


subject: CHEBI:95017


subject: CHEBI:95017


subject: UMLS:C5962499

subject_name: CDK2 Inhibitor BG-68501

object_name: Childhood Breast Carcinoma


subject: UMLS:C5962499

object_name: breast carcinoma


subject: UMLS:C5962499

object_name: breast cancer


subject: UMLS:C5962499

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5962499

object_name: hormone receptor-positive breast cancer


subject: UMLS:C5962499

object_name: Hormone receptor negative HER2 positive breast cancer


subject: UMLS:C5962499

object_name: triple-negative breast carcinoma


subject: UMLS:C5962499


subject: UMLS:C5962499


subject: UMLS:C5962499

object_name: ovarian cancer


subject: UMLS:C5962499

object_name: ovarian neoplasm


subject: UMLS:C5962499

object_name: ovarian carcinoma


subject: UMLS:C5962499

object_name: bladder tumor


subject: UMLS:C5962499

object_name: urinary bladder carcinoma


subject: UMLS:C5962499

object_name: urinary bladder cancer


subject: UMLS:C5962499

object_name: childhood bladder carcinoma


subject: UMLS:C5962499

object_name: Stomach cancer


subject: UMLS:C5962499

object_name: gastric cancer


subject: UMLS:C5962499

object_name: endometrial cancer


subject: UMLS:C5962499

object_name: uterine corpus cancer


subject: UMLS:C5962499

object_name: endometrial carcinoma


subject: UMLS:C5962499

object_name: small cell lung carcinoma


subject: UMLS:C5962499

object_name: gastroesophageal cancer


subject: UMLS:C5908016

subject_name: CDK4 Inhibitor BGB-43395

object_name: Childhood Breast Carcinoma


subject: UMLS:C5908016

object_name: breast carcinoma


subject: UMLS:C5908016

object_name: breast cancer


subject: UMLS:C5908016

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5908016

object_name: hormone receptor-positive breast cancer


subject: UMLS:C5908016

object_name: Hormone receptor negative HER2 positive breast cancer


subject: UMLS:C5908016

object_name: triple-negative breast carcinoma


subject: UMLS:C5908016

object_name: prostate carcinoma


subject: UMLS:C5908016

object_name: prostate cancer


subject: UMLS:C5908016

object_name: ovarian cancer


subject: UMLS:C5908016

object_name: ovarian neoplasm


subject: UMLS:C5908016

object_name: ovarian carcinoma


subject: UMLS:C5908016

object_name: bladder tumor


subject: UMLS:C5908016

object_name: urinary bladder carcinoma


subject: UMLS:C5908016

object_name: urinary bladder cancer


subject: UMLS:C5908016

object_name: childhood bladder carcinoma


subject: UMLS:C5908016

object_name: Stomach cancer


subject: UMLS:C5908016

object_name: gastric cancer


subject: UMLS:C5908016

object_name: endometrial cancer


subject: UMLS:C5908016

object_name: uterine corpus cancer


subject: UMLS:C5908016

object_name: endometrial carcinoma


subject: UMLS:C5908016

object_name: small cell lung carcinoma


subject: UMLS:C5908016

object_name: gastroesophageal cancer


subject: CHEBI:91951

object_name: hormone receptor-positive breast cancer


subject: CHEBI:91951

object_name: Hormone receptor negative HER2 positive breast cancer


subject: CHEBI:91951


subject: CHEBI:91951


subject: CHEBI:91951


subject: CHEBI:91951


subject: CHEBI:91951


subject: CHEBI:91951


subject: CHEBI:91951


subject: CHEBI:91951


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: CHEBI:6931

subject_name: Midazolam

object_name: Nausea, CTCAE_5


subject: CHEBI:6931

object_name: Nausea


subject: CHEBI:6931

object_name: Nausea, CTCAE_3


subject: PUBCHEM.COMPOUND:121489720

subject_name: darolutamide

object_name: Prostatic Cancer, Castration-Resistant


subject: UMLS:C4053669


subject: CHEBI:68534

subject_name: Enzalutamide


subject: CHEBI:2955

subject_name: Azithromycin

object_name: Pneumonia caused by SARS-CoV-2


subject: CHEBI:74705

subject_name: Met-Leu


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:17026

subject_name: Progesterone


subject: CHEBI:4445

subject_name: Desflurane

object_name: cervical cancer


subject: CHEBI:4445

object_name: cervical carcinoma


subject: CHEBI:4445

object_name: ovarian cancer


subject: CHEBI:4445

object_name: ovarian neoplasm


subject: CHEBI:4445

object_name: ovarian carcinoma


subject: CHEBI:4445

object_name: uterine fibroid


subject: CHEBI:4445

object_name: cholecystitis


subject: CHEBI:4445

object_name: Cholecystitis, CTCAE 3.0


subject: CHEBI:4445

object_name: Cholecystitis, CTCAE 5.0


subject: CHEBI:4445

object_name: ovarian cyst


subject: CHEBI:8802

subject_name: Remifentanil


subject: CHEBI:8802


subject: CHEBI:8802


subject: CHEBI:8802


subject: CHEBI:8802


subject: CHEBI:8802


subject: CHEBI:8802


subject: CHEBI:8802


subject: CHEBI:8802


subject: CHEBI:8802


subject: CHEBI:39048

subject_name: ADA

object_name: severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency


subject: CHEBI:39048

object_name: severe combined immunodeficiency


subject: UNII:8S5OIN36X4

subject_name: Seviteronel

object_name: prostate carcinoma


subject: UNII:8S5OIN36X4

object_name: prostate cancer


subject: CHEBI:7774

subject_name: Zofran

object_name: Chemotherapy-induced nausea and vomiting


subject: CHEBI:7773

subject_name: Ondansetron


subject: UMLS:C3273249

subject_name: Topical Wound Spray HP802-247

object_name: Varicose Ulcer


subject: CHEBI:232048

object_name: adult lymphoma


subject: CHEBI:232048

object_name: lymphoma


subject: CHEBI:232048

object_name: pediatric lymphoma


subject: CHEBI:232048

object_name: Solid Neoplasm


subject: CHEBI:232048

object_name: cancer


subject: CHEBI:232048

object_name: neoplasm


subject: UMLS:C2985180

subject_name: Debio 0932


subject: UMLS:C2985180


subject: UMLS:C2985180


subject: UMLS:C2985180


subject: UMLS:C2985180


subject: UMLS:C2985180


subject: CHEBI:50730

subject_name: Montelukast

object_name: Wheezing


subject: CHEBI:50730

object_name: Wheezing, CTCAE


subject: CHEBI:230508

subject_name: birabresib

object_name: plasma cell myeloma


subject: CHEBI:230508

object_name: acute lymphoblastic leukemia


subject: CHEBI:230508

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:230508

object_name: acute myeloid leukemia


subject: CHEBI:230508

object_name: diffuse large B-cell lymphoma


subject: CHEBI:230508

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:230508

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: MESH:C000605331


subject: MESH:C000605331


subject: MESH:C000605331


subject: MESH:C000605331


subject: MESH:C000605331


subject: MESH:C000605331


subject: MESH:C000605331


subject: UMLS:C3641185


subject: UMLS:C3641185


subject: UMLS:C3641185


subject: UMLS:C3641185


subject: UMLS:C3641185


subject: UMLS:C3641185


subject: UMLS:C3641185


subject: CHEBI:231425

subject_name: tolvaptan

object_name: congestive heart failure


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Miller-Dieker lissencephaly syndrome


subject: CHEBI:63791

object_name: myoclonic dystonia 11


subject: UMLS:C2981842

object_name: Acne inversa


subject: CHEBI:9241

subject_name: Spironolactone

object_name: Hyperkalemia, CTCAE


subject: CHEBI:9241

object_name: Hyperkalemia


subject: CHEBI:75832

subject_name: ferrous sulfate

object_name: Iron deficiency


subject: DRUGBANK:DB10553

subject_name: Peanut

object_name: peanut allergy


subject: DRUGBANK:DB10553

object_name: food allergy


subject: DRUGBANK:DB10553

object_name: Hypersensitivity reaction caused by food


subject: DRUGBANK:DB10553

object_name: IgE responsiveness, atopic


subject: UMLS:C5577555

subject_name: Opdualag

object_name: cancer


subject: UNII:AF75XOF6W3

subject_name: Relatlimab


subject: UMLS:C3827149


subject: UMLS:C3540798

subject_name: Food allergenic extracts

object_name: Adverse effects


subject: UMLS:C1446647

subject_name: Milk antigen


subject: DRUGBANK:DB10543

subject_name: Cow milk


subject: UMLS:C0444318

subject_name: Milk Specimen


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: outcomes general quality of life


subject: UMLS:C5848866

object_name: Perceived quality of life


subject: UMLS:C5848866

object_name: Good quality of life


subject: UMLS:C5848866

object_name: overall survival


subject: UMLS:C5237963

subject_name: ADC SKB264

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C0081937

subject_name: Dipeptidyl-Peptidase IV

object_name: type 2 diabetes mellitus


subject: PR:000001341

subject_name: dipeptidyl peptidase 4


subject: UNII:8V6OK1I088

subject_name: meglitinide


subject: PUBCHEM.COMPOUND:140987867

subject_name: Sulfonylurea


subject: CHEBI:76983

subject_name: N-sulfonylurea


subject: UMLS:C3536898

subject_name: Sulfonylurea [EPC]


subject: CHEBI:50990

subject_name: thiazolidinediones


subject: UMLS:C3541957

subject_name: Thiazolidinediones, blood glucose lowering drugs


subject: CHEBI:9927

subject_name: Valsartan

object_name: Moderate albuminuria


subject: UMLS:C1250042

subject_name: oxytocin nasal spray

object_name: Addictive benzodiazepine use


subject: CHEBI:31859

subject_name: Modafinil

object_name: methamphetamine dependence


subject: CHEBI:90343

object_name: Safety Issues


subject: DRUGBANK:DB18683

object_name: glioblastoma


subject: DRUGBANK:DB18683

object_name: Brain Stem Glioblastoma


subject: DRUGBANK:DB18683

object_name: glioma susceptibility 1


subject: DRUGBANK:DB18683

object_name: Childhood Glioblastoma


subject: DRUGBANK:DB18683

object_name: adult glioblastoma


subject: UMLS:C5188022

subject_name: Adhansia XR

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UMLS:C5188022


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:3207

object_name: anosmia


subject: CHEBI:3207

object_name: Anosmia, CTCAE


subject: UMLS:C3832695

subject_name: Budesonide Nasal (Brand Name)


subject: UMLS:C3832695


subject: UMLS:C3832695


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: small cell lung carcinoma


subject: UMLS:C3827082


subject: CHEBI:4911

subject_name: Etoposide


subject: GTOPDB:12969

subject_name: tarlatamab


subject: UNII:74X82ST8Q1

subject_name: TARLATAMAB


subject: UMLS:C4687660

subject_name: AMG 757


subject: UNII:VR86R11J7J

subject_name: mivebresib

object_name: cancer


subject: UNII:VR86R11J7J

object_name: neoplasm


subject: UNII:VR86R11J7J

object_name: Childhood Breast Carcinoma


subject: UNII:VR86R11J7J

object_name: breast carcinoma


subject: UNII:VR86R11J7J

object_name: breast cancer


subject: UNII:VR86R11J7J

object_name: prostate carcinoma


subject: UNII:VR86R11J7J

object_name: prostate cancer


subject: UNII:VR86R11J7J


subject: UNII:VR86R11J7J

object_name: non-small cell lung carcinoma


subject: UNII:VR86R11J7J

object_name: adult acute myeloid leukemia


subject: UNII:VR86R11J7J

object_name: childhood acute myeloid leukemia


subject: UNII:VR86R11J7J

object_name: acute myeloid leukemia


subject: UNII:VR86R11J7J

object_name: non-Hodgkin lymphoma


subject: UNII:VR86R11J7J

object_name: plasma cell myeloma


subject: UMLS:C4053689


subject: UMLS:C4053689


subject: UMLS:C4053689


subject: UMLS:C4053689


subject: UMLS:C4053689


subject: UMLS:C4053689


subject: UMLS:C4053689


subject: UMLS:C4053689


subject: UMLS:C4053689


subject: UMLS:C4053689


subject: UMLS:C4053689


subject: UMLS:C4053689


subject: UMLS:C4053689


subject: UMLS:C4053689


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: RXCUI:659877

subject_name: Gardasil

object_name: Anal intraepithelial neoplasia


subject: RXCUI:659877

object_name: Autoimmune neutropenia


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C3257527

subject_name: mango extract

object_name: Overweight or obesity


subject: DRUGBANK:DB10657

subject_name: Mango


subject: UNII:CEGM9YBNGD

subject_name: Selpercatinib

object_name: Recurrent Thyroid Carcinoma


subject: UNII:CEGM9YBNGD

object_name: thyroid cancer


subject: UNII:CEGM9YBNGD

object_name: poorly differentiated thyroid gland carcinoma


subject: UNII:CEGM9YBNGD

object_name: thyroid gland squamous cell carcinoma


subject: UNII:CEGM9YBNGD

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: UNII:CEGM9YBNGD

object_name: thyroid gland papillary carcinoma


subject: UMLS:C0879286

subject_name: EGFR Inhibitor BIBX 1382

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:6121

subject_name: Ketamine

object_name: Terminal illness


subject: UMLS:C2355103

object_name: kidney disorder


subject: UMLS:C2355103

object_name: aortic aneurysm


subject: UMLS:C2355103

object_name: Aortic aneurysm without mention of rupture NOS


subject: CHEBI:6801

subject_name: Metformin

object_name: peripheral vascular disease


subject: CHEBI:6801

object_name: peripheral arterial disease


subject: CHEBI:184693

subject_name: GRANISETRON

object_name: post operative nausea and vomiting


subject: CHEBI:231679

subject_name: ipilimumab

object_name: ocular melanoma


subject: PUBCHEM.COMPOUND:137634027

object_name: Kala-Azar


subject: PUBCHEM.COMPOUND:137634027

object_name: cutaneous leishmaniasis


subject: UNII:QAU2EGM5Q7


subject: UNII:QAU2EGM5Q7


subject: UMLS:C0042210

subject_name: Vaccines

object_name: arthritis


subject: UMLS:C0042210

object_name: Arthritis, CTCAE


subject: UMLS:C0042210

object_name: psoriatic arthritis


subject: UMLS:C0042210

object_name: Crohn disease


subject: UMLS:C0042210

object_name: rheumatoid arthritis


subject: UMLS:C0042210

object_name: Arthritis due to inflammatory bowel disease


subject: UMLS:C0042210

object_name: ankylosing spondylitis


subject: UMLS:C0042210

object_name: psoriasis


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Advanced renal cell carcinoma


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:229221

subject_name: Fruquintinib

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:229221

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:229221

object_name: sarcoma


subject: CHEBI:229221

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:229221

object_name: soft tissue sarcoma


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: arthroplasty; complications


subject: CHEBI:5062

subject_name: Finasteride

object_name: Stage II Prostate Cancer AJCC v6


subject: CHEBI:5062

object_name: Stage II Prostate Cancer AJCC v8


subject: CHEBI:5062

object_name: Carcinoma of the prostate stage II


subject: CHEBI:5062

object_name: Stage II Prostate Cancer AJCC v7


subject: CHEBI:5062

object_name: prostate adenocarcinoma


subject: PUBCHEM.COMPOUND:3367

object_name: Myelofibrosis due to another disorder


subject: PUBCHEM.COMPOUND:3367

object_name: hematologic disorder


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: UNII:XZG407XE0Y

subject_name: ITACITINIB ADIPATE

object_name: acute leukemia


subject: UNII:XZG407XE0Y

object_name: Myelodysplasia


subject: UNII:XZG407XE0Y

object_name: Adult Myelodysplastic Syndrome


subject: UNII:XZG407XE0Y

object_name: childhood myelodysplastic syndrome


subject: UNII:XZG407XE0Y

object_name: Myelodysplastic Syndrome, CTCAE


subject: UNII:XZG407XE0Y


subject: UNII:XZG407XE0Y


subject: UNII:XZG407XE0Y

object_name: myelofibrosis


subject: UMLS:C5204064

subject_name: Itacitinib Adipate


subject: UMLS:C5204064


subject: UMLS:C5204064


subject: UMLS:C5204064


subject: UMLS:C5204064


subject: UMLS:C5204064


subject: UMLS:C5204064


subject: UMLS:C5204064


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: UNII:365052M0DK

subject_name: Inarigivir soproxil

object_name: chronic hepatitis B virus infection


subject: UNII:365052M0DK

object_name: hepatitis B


subject: UMLS:C5139818


subject: UMLS:C5139818


subject: CHEBI:60481


subject: PR:000008953

subject_name: insulin-like growth factor-binding protein 7


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: diabetes mellitus


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: carcinoma of esophagus


subject: UNII:PVI5M0M1GW

object_name: esophageal cancer


subject: UNII:PVI5M0M1GW

object_name: Childhood Esophageal Carcinoma


subject: UNII:PVI5M0M1GW

object_name: neoplasm of esophagus


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UMLS:C2607231

subject_name: ABT 335

object_name: inherited lipid metabolism disorder


subject: UMLS:C2607231

object_name: Dyslipidemia


subject: UMLS:C2607231

object_name: kidney disorder


subject: UMLS:C2607231

object_name: impaired renal function disease


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEBI:38545


subject: DRUGBANK:DB17928

object_name: Varicose Ulcer


subject: PUBCHEM.COMPOUND:16051933

subject_name: DESMOPRESSIN

object_name: Acute Stroke


subject: UMLS:C3641718

subject_name: proellex

object_name: Decreased liver function


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: habitual spontaneous abortion


subject: CHEBI:201431

object_name: pregnancy loss, recurrent, susceptibility to, 1


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form

object_name: liver carcinoma


subject: UMLS:C2744172

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C2744172

object_name: obesity


subject: UMLS:C2744172

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:118204185

subject_name: Vutiglabridin

object_name: Parkinson disease


subject: DRUGBANK:DB18781


subject: CHEMBL.COMPOUND:CHEMBL4297681

object_name: Childhood Breast Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297681

object_name: breast carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297681

object_name: breast cancer


subject: CHEMBL.COMPOUND:CHEMBL4297681

object_name: sexual disorder


subject: CHEMBL.COMPOUND:CHEMBL4297681

object_name: physiological sexual disorder


subject: CHEMBL.COMPOUND:CHEMBL4297681

object_name: Disorder of nipple


subject: CHEMBL.COMPOUND:CHEMBL4297681

object_name: Sexual Arousal Disorder


subject: CHEMBL.COMPOUND:CHEMBL4297681

object_name: neuropathy


subject: PUBCHEM.COMPOUND:3081351

object_name: adrenocortical insufficiency


subject: PUBCHEM.COMPOUND:3081351

object_name: Adrenal Insufficiency, CTCAE


subject: DRUGBANK:DB16486

object_name: Chronic small plaque psoriasis


subject: DRUGBANK:DB16486

object_name: psoriasis


subject: CHEBI:232799

subject_name: insulin lispro

object_name: type 1 diabetes mellitus 1


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: Angina pectoris


subject: CHEBI:68558

object_name: heart disorder


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan

object_name: Malignant neoplasm of female breast


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UMLS:C3640943


subject: UMLS:C1699394

subject_name: Hylenex

object_name: Carcinoma breast stage IV


subject: UMLS:C1699394


subject: CHEBI:4708

subject_name: Doxazosin

object_name: alcohol abuse


subject: CHEBI:4708

object_name: post-traumatic stress disorder


subject: UNII:71492GE1FX

subject_name: Benralizumab

object_name: Asthmatic pulmonary eosinophilia


subject: CHEBI:188559

subject_name: Palovarotene

object_name: myositis ossificans


subject: CHEBI:188559

object_name: fibrodysplasia ossificans progressiva


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Kinetic tremor


subject: UMLS:C5237342

subject_name: Gallium-based Bone Resorption Inhibitor AP-002

object_name: Childhood Solid Neoplasm


subject: UMLS:C5237342

object_name: Adult Solid Neoplasm


subject: UMLS:C5237342

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:3086400

subject_name: Norprolac

object_name: ovarian hyperstimulation syndrome


subject: PUBCHEM.COMPOUND:55645

subject_name: QUINAGOLIDE


subject: UMLS:C0591881


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Metastatic Malignant Solid Neoplasm


subject: GTOPDB:9592

object_name: Disseminated Malignant Neoplasm


subject: GTOPDB:9592

object_name: Embolism, Tumor


subject: GTOPDB:9592

object_name: Neoplasm Metastasis


subject: GTOPDB:9592

object_name: Advanced cancer


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Childhood Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:14907381

object_name: Malignant Solid Neoplasm


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: UMLS:C5238977

subject_name: BNT 312


subject: UMLS:C5238977


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: GTOPDB:10492

subject_name: envafolimab

object_name: myxofibrosarcoma


subject: GTOPDB:10492

object_name: undifferentiated pleomorphic sarcoma


subject: GTOPDB:10492

object_name: Childhood Undifferentiated Pleomorphic Sarcoma


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UMLS:C4329339


subject: UMLS:C4329339


subject: UMLS:C4329339


subject: CHEBI:231679

subject_name: ipilimumab


subject: UNII:J43DL56H6M

subject_name: foralumab

object_name: type 2 diabetes mellitus


subject: UNII:J43DL56H6M


subject: UNII:J43DL56H6M

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C2987422


subject: UMLS:C2987422


subject: UMLS:C2987422


subject: UMLS:C0001924

subject_name: Albumins

object_name: Severe Dengue


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Childhood Large Cell Lymphoma


subject: UNII:4F4X42SYQ6

object_name: reticulosarcoma


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C2987725


subject: UMLS:C2987725


subject: UMLS:C2987725

object_name: follicular lymphoma


subject: UMLS:C2987725

object_name: non-Hodgkin lymphoma


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Crohn disease


subject: DRUGBANK:DB14297

subject_name: Arnica montana

object_name: Skin Bruise


subject: DRUGBANK:DB14297

object_name: Easy Bruising


subject: DRUGBANK:DB14297

object_name: Ecchymosis


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: hepatitis C


subject: PUBCHEM.COMPOUND:46783403

object_name: HIV infection


subject: CHEMBL.COMPOUND:CHEMBL2108661

subject_name: VEHICLE

object_name: Diabetic foot ulcer


subject: CHEBI:391960

subject_name: Darifenacin

object_name: Post-Operative Pain


subject: CHEBI:391960

object_name: Renal Colic, CTCAE


subject: CHEBI:391960

object_name: renal colic


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: optic nerve disorder


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:44814

object_name: alpha 1-antitrypsin deficiency


subject: UMLS:C0908957


subject: CHEBI:74088

object_name: breast neoplasm


subject: CHEBI:74007


subject: CHEBI:73805

subject_name: Ala-Ile


subject: UNII:19HY34R6UN

object_name: metastatic colorectal cancer


subject: CHEBI:49960

subject_name: Vandetanib

object_name: cancer


subject: CHEBI:49960

object_name: neoplasm


subject: CHEBI:90227

subject_name: Selumetinib


subject: CHEBI:90227


subject: CHEBI:90227

object_name: non-small cell lung carcinoma


subject: UMLS:C0040615

subject_name: Antipsychotic Agents

object_name: schizophrenia


subject: UNII:612BYT76F3


subject: MESH:D053061

subject_name: Herpes Zoster Vaccine

object_name: herpes zoster


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Metastatic Renal Cell Carcinoma


subject: UMLS:C0013227

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C3537265

subject_name: LY573636 sodium


subject: UMLS:C3537265


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: CD20 Positive


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: Mantle cell lymphoma refractory


subject: PUBCHEM.COMPOUND:3368

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Diffuse large B-cell lymphoma recurrent


subject: PUBCHEM.COMPOUND:3368

object_name: Follicular lymphoma refractory


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: Chronic lymphocytic leukaemia refractory


subject: UNII:I031V2H011

object_name: Recurrent Chronic Lymphoid Leukemia


subject: UNII:I031V2H011

object_name: B-cell small lymphocytic lymphoma refractory


subject: UNII:I031V2H011

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UNII:I031V2H011


subject: UNII:I031V2H011

object_name: Mantle cell lymphoma recurrent


subject: UNII:I031V2H011


subject: UNII:I031V2H011


subject: UNII:I031V2H011

object_name: Follicular lymphoma recurrent


subject: UNII:I031V2H011

object_name: CD19 Positive


subject: UNII:I031V2H011


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: cardiovascular disorder


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: DRUGBANK:DB05506

object_name: type 2 diabetes mellitus


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: Osteopenia


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: lung cancer


subject: UMLS:C0919079

object_name: lung neoplasm


subject: UMLS:C0919079

object_name: lung carcinoma


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Metastatic Renal Cell Carcinoma


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: Abortion early


subject: UNII:SQ8A3S5101

subject_name: Fostamatinib

object_name: hematopoietic and lymphoid system neoplasm


subject: PUBCHEM.COMPOUND:67036325

subject_name: Danoprevir

object_name: hepatitis C


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: pervasive developmental disorder


subject: CHEBI:31236

object_name: autism


subject: CHEBI:31236

object_name: autism spectrum disorder


subject: UNII:24ZVH4C669

subject_name: Drotaverine hydrochloride

object_name: pancreas disorder


subject: UNII:24ZVH4C669

object_name: bile duct disorder


subject: CHEBI:135630

subject_name: Drotaverine


subject: CHEBI:135630


subject: CHEBI:95089

subject_name: Ipatasertib

object_name: Childhood Breast Carcinoma


subject: CHEBI:95089

object_name: breast carcinoma


subject: CHEBI:95089

object_name: breast cancer


subject: PUBCHEM.COMPOUND:160883

subject_name: Butylscopolamine

object_name: Acute gastroenteritis


subject: PUBCHEM.COMPOUND:160883

object_name: Abdominal pain


subject: PUBCHEM.COMPOUND:160883

object_name: Abdominal Pain, CTCAE


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: neonatal abstinence syndrome


subject: CHEBI:32599

object_name: prostate cancer


subject: CHEBI:32599

object_name: prostate neoplasm


subject: CHEBI:2948

subject_name: Azathioprine

object_name: Pemphigoid


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:145499

subject_name: Donepezil

object_name: Memory observations


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: multiple sclerosis


subject: CHEBI:28939

object_name: primary progressive multiple sclerosis


subject: CHEBI:28939

object_name: secondary progressive multiple sclerosis


subject: CHEBI:72296

subject_name: Apixaban

object_name: aortic stenosis symptomatic


subject: PUBCHEM.COMPOUND:126456119

subject_name: Lactoferrin

object_name: neonatal sepsis


subject: PUBCHEM.COMPOUND:126456119

object_name: Bacterial sepsis of newborn


subject: PR:000009978

subject_name: lactotransferrin


subject: PR:000009978


subject: UMLS:C0022942

subject_name: lactoferrin


subject: UMLS:C0022942


subject: UniProtKB:Q8TCD2

subject_name: LTF protein, human


subject: UniProtKB:Q8TCD2


subject: UMLS:C0591295

subject_name: corsodyl

object_name: Subgingival plaque


subject: UMLS:C0591295

object_name: periodontitis


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: Adult Rhabdomyosarcoma


subject: PUBCHEM.COMPOUND:135565596

object_name: rhabdomyosarcoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Childhood Rhabdomyosarcoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Ewing sarcoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Childhood Neuroblastoma


subject: PUBCHEM.COMPOUND:135565596

object_name: neuroblastoma


subject: PUBCHEM.COMPOUND:135565596

object_name: pediatric osteosarcoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Osteosarcoma


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:173077


subject: UMLS:C3273039


subject: UMLS:C3273039


subject: UMLS:C3273039


subject: UMLS:C3273039


subject: UMLS:C3273039


subject: UMLS:C3273039


subject: UMLS:C3273039


subject: UMLS:C3273039


subject: UMLS:C3273039


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Operative bleeding


subject: UNII:4WE915J1KX

subject_name: squalamine lactate

object_name: Wet age-related macular degeneration


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: genotype


subject: CHEBI:41774

object_name: breast neoplasm


subject: PUBCHEM.COMPOUND:73897520

object_name: Postprandial hyperglycemia


subject: UNII:726I6TE06G

subject_name: PRAMLINTIDE ACETATE


subject: UMLS:C1174779

subject_name: Symlin


subject: PUBCHEM.COMPOUND:139600705

subject_name: Pramlintide


subject: UMLS:C0001645

subject_name: Adrenergic beta-Antagonists

object_name: chronic kidney disease


subject: CHEBI:27470

subject_name: Folic acid

object_name: Other sickle-cell disorders with crisis, unspecified


subject: UMLS:C0282100

subject_name: Paludrine


subject: UMLS:C3827186

subject_name: Jobelyn


subject: UMLS:C1704311

subject_name: Antithrombotic Agents

object_name: atrial fibrillation


subject: UMLS:C1704311

object_name: Atrial Fibrillation by ECG Finding


subject: UMLS:C1704311

object_name: Atrial Fibrillation, CTCAE


subject: UMLS:C3536755

subject_name: Serotonin-3 Receptor Antagonist [EPC]

object_name: malignant soft tissue neoplasm


subject: UMLS:C3536755

object_name: sarcoma


subject: UMLS:C3536755

object_name: Chemotherapy-induced nausea and vomiting


subject: UMLS:C3536755

object_name: Effects of chemotherapy


subject: UMLS:C3536755

object_name: Adverse effects of medical drugs


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:64321

subject_name: Fosaprepitant


subject: CHEBI:64321


subject: CHEBI:64321


subject: CHEBI:64321


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:74088


subject: CHEBI:74088


subject: CHEBI:74088


subject: CHEBI:74007


subject: CHEBI:74007


subject: CHEBI:74007


subject: CHEBI:73805

subject_name: Ala-Ile


subject: CHEBI:73805


subject: CHEBI:73805


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: GTOPDB:10412

object_name: Sicca Syndrome


subject: GTOPDB:10412

object_name: Primary Sjögren's syndrome


subject: UNII:6RQ92PNH8Z


subject: UNII:6RQ92PNH8Z


subject: UMLS:C4705323


subject: UMLS:C4705323


subject: UNII:UG97LO5M8Y

subject_name: Tesetaxel

object_name: Childhood Breast Carcinoma


subject: UNII:UG97LO5M8Y

object_name: breast carcinoma


subject: UNII:UG97LO5M8Y

object_name: breast cancer


subject: CHEBI:8499

subject_name: Propranolol

object_name: pervasive developmental disorder


subject: CHEBI:8499

object_name: autism


subject: CHEBI:85974

subject_name: edoxaban tosylate hydrate

object_name: Nonvalvular atrial fibrillation


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban


subject: UNII:SQ8A3S5101

subject_name: Fostamatinib


subject: UNII:SQ8A3S5101

object_name: SARS-associated coronavirus as cause of disease classified elsewhere


subject: UNII:SQ8A3S5101

object_name: severe acute respiratory syndrome


subject: UNII:SQ8A3S5101

object_name: viral pneumonia


subject: UNII:SQ8A3S5101

object_name: severe acute respiratory syndrome (SARS) pneumonia


subject: UNII:SQ8A3S5101

object_name: pneumonia


subject: UNII:SQ8A3S5101

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:23359

subject_name: colchicine

object_name: pericarditis


subject: CHEBI:23359

object_name: Pericarditis, CTCAE


subject: CHEBI:23359

object_name: Recurrence


subject: CHEBI:23359

object_name: Recurrent Malignant Neoplasm


subject: CHEBI:23359

object_name: Recurrent disease


subject: CHEBI:23359

object_name: Recurrent tumor


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: chronic hepatitis B virus infection


subject: CHEBI:50275

object_name: hepatitis B


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: CHEBI:4903


subject: CHEBI:231594

subject_name: Norgestrel


subject: CHEBI:231594


subject: CHEBI:94366

subject_name: itraconazole


subject: CHEBI:94366


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: PUBCHEM.COMPOUND:135512673


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: HMDB:HMDB0015179


subject: UMLS:C1384659

object_name: lung cancer


subject: UMLS:C1384659

object_name: lung neoplasm


subject: UMLS:C1384659

object_name: lung carcinoma


subject: CHEBI:49960

subject_name: Vandetanib


subject: CHEBI:49960


subject: CHEBI:49960


subject: CHEBI:76018

subject_name: Riociguat

object_name: systemic sclerosis


subject: UMLS:C2717562


subject: CHEBI:17933

subject_name: Calcifediol

object_name: chronic kidney disease


subject: CHEBI:17933

object_name: end stage renal failure


subject: UMLS:C0521942

subject_name: Angiotensin II receptor antagonist

object_name: MINOCA


subject: UMLS:C0001645

subject_name: Adrenergic beta-Antagonists


subject: UNII:K5CXA4X5U8

subject_name: relmacabtagene autoleucel

object_name: large B-cell lymphoma


subject: UNII:K5CXA4X5U8

object_name: follicular lymphoma


subject: UNII:K5CXA4X5U8

object_name: B-cell neoplasm


subject: PUBCHEM.COMPOUND:145946918

subject_name: SPINOSAD

object_name: Pediculus humanus capitis infestation


subject: UMLS:C1440867

subject_name: lactoferrin, bovine

object_name: Parageusia


subject: UNII:795J01AE70

subject_name: DEXPRAMIPEXOLE DIHYDROCHLORIDE

object_name: pulmonary eosinophilia


subject: UNII:795J01AE70

object_name: Asthmatic pulmonary eosinophilia


subject: UNII:795J01AE70

object_name: Asthma attack


subject: UNII:795J01AE70

object_name: Acute asthma


subject: UMLS:C5238200

subject_name: Dexpramipexole Dihydrochloride


subject: UMLS:C5238200


subject: UMLS:C5238200


subject: UMLS:C5238200


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: neurofibromatosis 1


subject: CHEBI:32016

object_name: neurofibromatosis type 1


subject: CHEBI:32016

object_name: precancerous condition


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: Helicobacter pylori infection


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: metastatic prostate carcinoma


subject: CHEBI:135919

subject_name: Nesiritide

object_name: hypertension


subject: CHEBI:135919

object_name: Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:43805

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: CHEBI:151

subject_name: ISOCITRIC ACID

object_name: cancer


subject: CHEBI:151

object_name: neoplasm


subject: CHEBI:151

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:151

object_name: Embolism, Tumor


subject: CHEBI:151

object_name: Neoplasm Metastasis


subject: UMLS:C0360094

subject_name: iv lidocaine

object_name: Post-Operative Pain


subject: CHEBI:44185

subject_name: Methotrexate

object_name: Drug toxicity


subject: CHEBI:44185

object_name: Effects of chemotherapy


subject: UniProtKB:P47802

subject_name: MTX1_MOUSE Metaxin-1 (sprot)

object_name: gestational trophoblastic neoplasm


subject: UniProtKB:P47802


subject: UniProtKB:P47802


subject: PR:000010755


subject: PR:000010755


subject: PR:000010755


subject: CHEBI:27666

subject_name: Dactinomycin


subject: CHEBI:27666


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: peripheral vascular disease


subject: CHEBI:15927

object_name: peripheral arterial disease


subject: CHEBI:74705

subject_name: Met-Leu

object_name: ocular hypertension


subject: CHEBI:74705

object_name: Ocular hypertension


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: CHEBI:64816

object_name: Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:64816

object_name: Metastatic Soft Tissue Sarcoma


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: UMLS:C4330473

subject_name: Idronoxil Suppository NOX66


subject: UMLS:C4330473


subject: UMLS:C1705207

subject_name: Endostar

object_name: esophageal disorder


subject: CHEBI:31652

subject_name: Gimeracil


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: UMLS:C5556477

object_name: non-small cell lung carcinoma


subject: CHEBI:42724

subject_name: levamfetamine

object_name: nicotine dependence


subject: CHEBI:35338

subject_name: amphetamines


subject: CHEBI:132233

subject_name: Amphetamine


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: Light for dates


subject: CHEBI:46081

subject_name: Fluconazole


subject: UNII:19FUJ2C58T

subject_name: Ginkgo biloba

object_name: schizophrenia


subject: CHEBI:6931

subject_name: Midazolam

object_name: skin disease caused by bacterial infection


subject: CHEBI:6931

object_name: cellulitis


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEBI:38545


subject: PUBCHEM.COMPOUND:11511576

subject_name: Tedizolid phosphate


subject: PUBCHEM.COMPOUND:11511576


subject: CHEBI:82717

subject_name: Tedizolid


subject: CHEBI:82717


subject: UMLS:C2986882

subject_name: sifalimumab

object_name: EXCESS LMW-DNA


subject: UMLS:C2986882

object_name: lupus vulgaris


subject: UMLS:C2986882

object_name: lupus erythematosus


subject: UMLS:C2986882

object_name: discoid lupus erythematosus


subject: UMLS:C4548958


subject: UMLS:C4548958


subject: UMLS:C4548958


subject: UMLS:C4548958


subject: PUBCHEM.COMPOUND:46930997

subject_name: obatoclax

object_name: acute myeloid leukemia


subject: UNII:QN4128B52A

subject_name: Obatoclax


subject: CHEBI:229764

subject_name: Selinexor

object_name: Lymphoma, Extranodal NK-T-Cell


subject: UNII:3BY9Z3M34G

subject_name: Golidocitinib


subject: CHEBI:8499

subject_name: Propranolol

object_name: post term pregnancy


subject: CHEBI:91951

object_name: pancreatic neoplasm


subject: CHEBI:91951

object_name: exocrine pancreatic carcinoma


subject: CHEBI:91951

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:146662729

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:146662729

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:146662729

object_name: breast cancer


subject: PUBCHEM.COMPOUND:146662729


subject: PUBCHEM.COMPOUND:146662729


subject: PUBCHEM.COMPOUND:146662729


subject: PUBCHEM.COMPOUND:146662729


subject: UNII:TW6044C3O6


subject: UNII:TW6044C3O6


subject: UNII:TW6044C3O6


subject: UNII:TW6044C3O6


subject: UNII:TW6044C3O6


subject: UNII:TW6044C3O6


subject: UNII:TW6044C3O6


subject: CHEBI:36704

subject_name: Imiquimod

object_name: prostate adenocarcinoma


subject: UMLS:C4745020

object_name: Adult Solid Neoplasm


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: cancer


subject: UNII:28X28X9OKV

object_name: neoplasm


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: bulimia nervosa


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Breast cancer stage II


subject: CHEBI:31355

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:31355

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:31355

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:31355

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IA Breast Cancer AJCC v7


subject: CHEBI:31355

object_name: stage IA breast cancer


subject: CHEBI:31355

object_name: estrogen receptor-negative breast cancer


subject: CHEBI:31355

object_name: progesterone receptor-negative breast cancer


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: triple-negative breast carcinoma


subject: CHEBI:231005

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:231005


subject: CHEBI:231005


subject: CHEBI:231005


subject: CHEBI:231005


subject: CHEBI:231005

object_name: male breast carcinoma


subject: CHEBI:231005

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:231005

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:231005

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:231005

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:231005

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:231005

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:231005

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:231005

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:231005

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:231005

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:231005

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:231005

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:231005

object_name: Stage IB Breast Cancer AJCC v7


subject: CHEBI:231005

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:231005

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:231005

object_name: Stage IA Breast Cancer AJCC v7


subject: CHEBI:231005

object_name: stage IA breast cancer


subject: CHEBI:231005

object_name: estrogen receptor-negative breast cancer


subject: CHEBI:231005

object_name: progesterone receptor-negative breast cancer


subject: CHEBI:63587

subject_name: Eribulin

object_name: triple-negative breast carcinoma


subject: CHEBI:63587

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:63587

object_name: Breast cancer stage II


subject: CHEBI:63587

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:63587

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:63587

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:63587

object_name: male breast carcinoma


subject: CHEBI:63587

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:63587

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:63587

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:63587

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:63587

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:63587

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:63587

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:63587

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:63587

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:63587

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:63587

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:63587

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:63587

object_name: Stage IB Breast Cancer AJCC v7


subject: CHEBI:63587

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:63587

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:63587

object_name: Stage IA Breast Cancer AJCC v7


subject: CHEBI:63587

object_name: stage IA breast cancer


subject: CHEBI:63587

object_name: estrogen receptor-negative breast cancer


subject: CHEBI:63587

object_name: progesterone receptor-negative breast cancer


subject: CHEBI:60799

subject_name: Esketamine

object_name: Abnormal vascular flow


subject: CHEBI:94757

subject_name: Lomibuvir

object_name: chronic hepatitis C virus infection


subject: UMLS:C4045963


subject: UMLS:C5666894


subject: CHEBI:20993

subject_name: GLUCOSAMINE

object_name: Inflammation


subject: CHEBI:20993

object_name: knee pain chronic


subject: CHEBI:28393

subject_name: D-glucosamine


subject: CHEBI:28393


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN


subject: PUBCHEM.COMPOUND:5281767


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: prostate carcinoma


subject: CHEBI:79699

object_name: prostate cancer


subject: MESH:C478243

subject_name: fluad vaccine

object_name: influenza


subject: CHEBI:136046

subject_name: Ripasudil

object_name: corneal edema


subject: CHEBI:136046

object_name: Pseudophakic corneal edema


subject: CHEBI:136046

object_name: corneal endothelial dystrophy


subject: CHEBI:136046

object_name: congenital hereditary endothelial dystrophy of cornea


subject: CHEBI:136046

object_name: coronary microvascular disorder


subject: CHEBI:136046

object_name: bullous keratopathy


subject: CHEBI:136046

object_name: Corneal epithelial edema


subject: UMLS:C1579361

subject_name: Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)

object_name: endogenous depression


subject: UMLS:C1579361

object_name: major depressive disorder


subject: CHEBI:350546


subject: CHEBI:350546


subject: CHEBI:28790

subject_name: Serotonin


subject: CHEBI:28790


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: otitis externa


subject: CHEBI:100241

object_name: Otitis Externa, CTCAE


subject: UMLS:C0655013

subject_name: B3(Fv)-PE38KDEL recombinant immunotoxin

object_name: adult lymphoma


subject: UMLS:C0655013

object_name: lymphoma


subject: UMLS:C0655013

object_name: pediatric lymphoma


subject: CHEBI:5613

subject_name: Haloperidol

object_name: cannabinoid hyperemesis syndrome


subject: CHEBI:229764

subject_name: Selinexor

object_name: plasma cell myeloma


subject: CHEBI:142406

subject_name: ziconotide

object_name: neuralgia


subject: CHEBI:142406

object_name: Neuropathic pain


subject: CHEBI:142406

object_name: cancer


subject: CHEBI:142406

object_name: neoplasm


subject: CHEBI:142406

object_name: Pain, Intractable


subject: PUBCHEM.COMPOUND:16135415

subject_name: Ziconotide


subject: PUBCHEM.COMPOUND:16135415


subject: PUBCHEM.COMPOUND:16135415


subject: PUBCHEM.COMPOUND:16135415


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib

object_name: pancreatic neoplasm


subject: UNII:B2K5L1L8S9

object_name: exocrine pancreatic carcinoma


subject: UNII:B2K5L1L8S9

object_name: malignant pancreatic neoplasm


subject: UNII:B2K5L1L8S9

object_name: Pancreatic cancer non-resectable


subject: UNII:B2K5L1L8S9

object_name: pancreatic ductal adenocarcinoma


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: CHEBI:45863

subject_name: Paclitaxel


subject: PUBCHEM.COMPOUND:24892726

subject_name: Glucomannan

object_name: hypoglycemia


subject: PUBCHEM.COMPOUND:24892726

object_name: Blood glucose below reference range (finding)


subject: PUBCHEM.COMPOUND:24892726

object_name: Hypoglycemia, CTCAE


subject: CHEBI:60791

subject_name: Xylocard

object_name: traumatic encephalopathy


subject: CHEBI:60791

object_name: traumatic brain injury


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Labor Pain


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: dry eye syndrome


subject: PUBCHEM.COMPOUND:4715169

object_name: Dry Eye, CTCAE


subject: PUBCHEM.COMPOUND:4715169

object_name: Dryness of eye


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:64356


subject: CHEBI:64356


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: Locally Advanced Pancreatic Ductal Adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: CHEBI:175901

subject_name: Gemcitabine


subject: MESH:C520255


subject: CHEBI:45863


subject: CHEBI:27732

subject_name: Caffeine

object_name: HIV infection


subject: CHEBI:4551

subject_name: Digoxin


subject: CHEBI:5130

subject_name: Flurbiprofen


subject: CHEBI:50730

subject_name: Montelukast


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:8382

subject_name: Prednisone

object_name: Community-Acquired Pneumonia


subject: CHEBI:8382

object_name: cognitive disorder


subject: GTOPDB:6781

subject_name: tositumomab

object_name: Chronic lymphocytic leukaemia stage 1


subject: GTOPDB:6781

object_name: Chronic lymphocytic leukaemia stage 2


subject: GTOPDB:6781

object_name: Chronic lymphocytic leukaemia stage 4


subject: GTOPDB:6781

object_name: B-cell small lymphocytic lymphoma stage IV


subject: GTOPDB:6781

object_name: Chronic lymphocytic leukaemia stage 3


subject: GTOPDB:6781

object_name: B-cell small lymphocytic lymphoma stage III


subject: GTOPDB:6781

object_name: Lymphoid leukemia in remission


subject: UNII:0343IGH41U

subject_name: TOSITUMOMAB


subject: UNII:0343IGH41U


subject: UNII:0343IGH41U


subject: UNII:0343IGH41U


subject: UNII:0343IGH41U


subject: UNII:0343IGH41U


subject: UNII:0343IGH41U


subject: UMLS:C0879399


subject: UMLS:C0879399


subject: UMLS:C0879399


subject: UMLS:C0879399


subject: UMLS:C0879399


subject: UMLS:C0879399


subject: UMLS:C0879399


subject: UMLS:C0768182

subject_name: Bexxar


subject: UMLS:C0768182


subject: UMLS:C0768182


subject: UMLS:C0768182


subject: UMLS:C0768182


subject: UMLS:C0768182


subject: UMLS:C0768182


subject: CHEBI:135765

subject_name: Methylprednisolone hemisuccinate

object_name: multiple sclerosis


subject: UMLS:C5666878

subject_name: Anti-HLA-G/CD3 Bispecific Antibody JNJ-78306358

object_name: neoplasm


subject: UMLS:C0886287

subject_name: Papapver somniferum, opium, dried latex of poppy

object_name: opiate dependence


subject: CHEMBL.COMPOUND:CHEMBL2107914

subject_name: OPIUM


subject: UMLS:C0282575

subject_name: Micronutrients


subject: CHEBI:22586

subject_name: antioxidant


subject: UMLS:C0003402

subject_name: Antioxidants


subject: CHEBI:49575

subject_name: Diazepam

object_name: anxiety


subject: CHEBI:17045

subject_name: Nitrous oxide


subject: UMLS:C0350411

subject_name: Oxygen only product in gas for inhalation


subject: UMLS:C1174097

object_name: arteriosclerosis disorder


subject: UMLS:C1174097

object_name: atherosclerosis


subject: UMLS:C1174097

object_name: coronary artery disorder


subject: UMLS:C1174097

object_name: coronary atherosclerosis


subject: UMLS:C1174097

object_name: myocardial infarction


subject: UMLS:C1174097

object_name: Myocardial Infarction, CTCAE


subject: UMLS:C1174097

object_name: Myocardial Infarction by ECG Finding


subject: UMLS:C1174097

object_name: angina unstable


subject: UNII:9JX1L8VH4Z

object_name: HIV infection


subject: UNII:9JX1L8VH4Z

object_name: AIDS dementia


subject: CHEBI:76842

object_name: arthroplasty; complications


subject: CHEBI:76842

object_name: Periprosthetic fracture of hip


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: UMLS:C4087084

subject_name: TRX 818

object_name: neuroendocrine neoplasm


subject: UMLS:C4087084

object_name: pancreatic neuroendocrine tumor


subject: UMLS:C4087084

object_name: Neuroendocrine tumor of pancreas


subject: UMLS:C4087084

object_name: neuroendocrine carcinoma


subject: UMLS:C4087084

object_name: lung neuroendocrine neoplasm


subject: UMLS:C4087084

object_name: digestive system neuroendocrine tumor, grade 1/2


subject: UMLS:C4087084

object_name: digestive system neuroendocrine neoplasm


subject: CHEBI:176724

subject_name: Etiracetam

object_name: Status epilepticus


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: Neonatal disorder


subject: CHEBI:3614

object_name: puerperal infection


subject: UMLS:C5960695

subject_name: Anti-CDH3/MMAE Antibody-drug Conjugate BC3195

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C5960695

object_name: Advanced cancer


subject: CHEBI:38940

subject_name: Sunitinib

object_name: Mucosal lentiginous melanoma


subject: CHEBI:38940

object_name: acral lentiginous melanoma


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Metastatic leiomyosarcoma


subject: UMLS:C1519050

subject_name: PI3K inhibitors

object_name: T-Cell Lymphoma


subject: UMLS:C1519050

object_name: chronic lymphoproliferative disorder of NK-cells


subject: UMLS:C1519050

object_name: T-cell large granular lymphocyte leukemia


subject: CHEBI:50914

subject_name: EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor


subject: CHEBI:50914


subject: CHEBI:50914


subject: CHEMBL.COMPOUND:CHEMBL4650412

subject_name: OLESTRA

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEMBL.COMPOUND:CHEMBL4650412

object_name: obesity


subject: CHEMBL.COMPOUND:CHEMBL4650412

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:2791

subject_name: Clobetasol propionate

object_name: hand dermatosis


subject: CHEBI:205919

subject_name: Clobetasol


subject: UMLS:C4724885

subject_name: Neo-multiple TAA-loaded Dendritic Cell Vaccine

object_name: liver cancer


subject: CHEBI:75929

object_name: social phobia


subject: UMLS:C0982327

subject_name: PEGINTERFERON

object_name: hepatitis C


subject: UMLS:C0982327

object_name: chronic hepatitis C virus infection


subject: CHEBI:231594

subject_name: Norgestrel

object_name: type 2 diabetes mellitus


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: CHEBI:187893

subject_name: Baclofen

object_name: anxiety disorder


subject: CHEBI:9014

subject_name: Salsalate

object_name: Androgen excess


subject: UMLS:C1328149

object_name: thyroid tumor


subject: GTOPDB:13796

subject_name: serplulimab

object_name: small cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594550

subject_name: SERPLULIMAB


subject: UMLS:C4745029

subject_name: HLX 10


subject: DRUGBANK:DB17676

subject_name: Oxabact

object_name: nephrolithiasis, calcium oxalate


subject: UMLS:C3541397

subject_name: oil ingredients

object_name: Decreased circulating vitamin E concentration


subject: UMLS:C3541397

object_name: Fatty acid deficiency


subject: UMLS:C3541397

object_name: Childhood disinhibited attachment disorder


subject: UMLS:C3541397

object_name: Selenium deficiency


subject: UMLS:C3541397

object_name: Age-related immunodeficiency


subject: MESH:D009821

subject_name: Oils


subject: MESH:D009821


subject: MESH:D009821


subject: MESH:D009821


subject: MESH:D009821


subject: PR:000004089

subject_name: aldehyde oxidase


subject: PR:000004089


subject: PR:000004089


subject: PR:000004089


subject: PR:000004089


subject: PR:000022129

subject_name: acetylornithine deacetylase


subject: PR:000022129


subject: PR:000022129


subject: PR:000022129


subject: PR:000022129


subject: CHEBI:233453

object_name: Infection


subject: CHEBI:233453

object_name: infectious disease


subject: CHEBI:233453

object_name: Adverse Event Associated with Infection


subject: CHEBI:233453


subject: CHEBI:35854

subject_name: Valaciclovir


subject: CHEBI:35854


subject: CHEBI:35854


subject: CHEBI:35854


subject: CHEBI:65350

subject_name: lorcaserin hydrochloride

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:65350

object_name: obesity


subject: CHEBI:65350

object_name: Obesity, CTCAE


subject: CHEBI:8884

subject_name: Rocuronium

object_name: outcomes general quality of life


subject: CHEBI:8884

object_name: Perceived quality of life


subject: CHEBI:8884

object_name: Good quality of life


subject: CHEBI:8884

object_name: Postoperative Complications


subject: CHEBI:8884

object_name: Innate Inflammatory Response


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: kidney failure


subject: CHEBI:4466

object_name: Renal Failure, CTCAE


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UMLS:C0016004

subject_name: Beriplast P

object_name: Pleural effusion


subject: UMLS:C0016004

object_name: Pleural Effusion, CTCAE


subject: UMLS:C0016004

object_name: x-ray of chest: pleural effusion


subject: UNII:LAD0ZG7FFO

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:21634109

subject_name: Lacosamide

object_name: neuralgia


subject: PUBCHEM.COMPOUND:21634109

object_name: Neuropathic pain


subject: PUBCHEM.COMPOUND:21634109

object_name: neuropathy


subject: PUBCHEM.COMPOUND:21634109

object_name: neuropathy, painful


subject: CHEBI:3077

subject_name: Betamethasone

object_name: congenital pulmonary airway malformation


subject: UNII:I7MVZ8HDNU

subject_name: Remibrutinib

object_name: peanut allergy


subject: CHEBI:600103

subject_name: daptomycin

object_name: Wound Infection


subject: CHEBI:600103

object_name: Wound Infection, CTCAE


subject: CHEBI:2453

subject_name: Acyclovir

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:2453

object_name: obesity


subject: CHEBI:2453

object_name: Obesity, CTCAE


subject: UMLS:C1506837

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C1506837

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C1506837

object_name: sarcoma


subject: UMLS:C1506837

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C1506837

object_name: soft tissue sarcoma


subject: CHEBI:85078

subject_name: Dapagliflozin


subject: CHEBI:85078


subject: CHEBI:85078


subject: PUBCHEM.COMPOUND:44573417

subject_name: METFORMIN XR


subject: PUBCHEM.COMPOUND:44573417


subject: PUBCHEM.COMPOUND:44573417


subject: PUBCHEM.COMPOUND:3043660


subject: PUBCHEM.COMPOUND:3043660


subject: PUBCHEM.COMPOUND:3043660


subject: UNII:RZ22DI43TP

subject_name: PROTHROMBIN COMPLEX CONCENTRATE

object_name: Surgical procedure finding


subject: UNII:RZ22DI43TP

object_name: Hemorrhage


subject: UMLS:C0072434

subject_name: prothrombin complex concentrates


subject: UMLS:C0072434


subject: UMLS:C4048712

subject_name: factor IX complex


subject: UMLS:C4048712


subject: CHEBI:176795

subject_name: pyridinium chlorochromate


subject: CHEBI:176795


subject: UNII:03ZI7ZZW5Q


subject: UNII:03ZI7ZZW5Q


subject: UNII:1Y26ZZ0OTM

subject_name: Magnesium-l-threonate

object_name: magnesium measurement


subject: UNII:1Y26ZZ0OTM

object_name: Menopausal syndrome


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone

object_name: Poor response to ovulation induction


subject: PUBCHEM.COMPOUND:134506

object_name: female infertility


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: UNII:8BR2SOL3L1

object_name: Metastatic castration-resistant prostate cancer


subject: UNII:8BR2SOL3L1

object_name: prostate carcinoma


subject: UNII:8BR2SOL3L1

object_name: prostate cancer


subject: DRUGBANK:DB12813

subject_name: Radium Ra-223


subject: DRUGBANK:DB12813


subject: DRUGBANK:DB12813


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: HIV-1 infection


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: Chemotherapy-induced nausea and vomiting


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: PUBCHEM.COMPOUND:5339

subject_name: Sulfasalazine


subject: UMLS:C5205023

subject_name: OX40L-expressing Oncolytic Adenovirus DNX-2440

object_name: colorectal cancer


subject: UMLS:C5205023

object_name: colorectal carcinoma


subject: UMLS:C5205023

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5205023

object_name: Metastatic malignant neoplasm to liver


subject: UMLS:C5205023

object_name: colon cancer liver metastasis


subject: UMLS:C5205023

object_name: renal cell adenocarcinoma


subject: UMLS:C5205023

object_name: kidney cancer


subject: UMLS:C5205023

object_name: renal cell carcinoma


subject: UMLS:C5205023

object_name: childhood kidney cell carcinoma


subject: UMLS:C5205023

object_name: Childhood Breast Carcinoma


subject: UMLS:C5205023

object_name: breast carcinoma


subject: UMLS:C5205023

object_name: breast cancer


subject: UMLS:C5205023

object_name: Stomach cancer


subject: UMLS:C5205023

object_name: gastric cancer


subject: UMLS:C5205023

object_name: periampullary adenocarcinoma


subject: UMLS:C5205023

object_name: Plexosarcoma


subject: UMLS:C5205023

object_name: squamous cell carcinoma


subject: UMLS:C5205023

object_name: melanoma


subject: UMLS:C5205023

object_name: malignant soft tissue neoplasm


subject: UMLS:C5205023

object_name: sarcoma


subject: PUBCHEM.COMPOUND:58008990

subject_name: Duvelisib

object_name: head and neck squamous cell carcinoma


subject: UNII:PP0SHH6V16

subject_name: Alirocumab

object_name: myocardial infarction


subject: UNII:PP0SHH6V16

object_name: Myocardial Infarction, CTCAE


subject: UNII:PP0SHH6V16

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:9555

subject_name: Tioguanine

object_name: Langerhans cell histiocytosis


subject: CHEBI:9555

object_name: Langerhans cell histiocytosis specific to childhood


subject: CHEBI:9555

object_name: Langerhans cell histiocytosis specific to adulthood


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: UMLS:C1688539

object_name: Torticollis


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: Infection


subject: UNII:6GNT3Y5LMF

object_name: infectious disease


subject: UNII:6GNT3Y5LMF

object_name: Adverse Event Associated with Infection


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:63598


subject: CHEBI:63598


subject: UMLS:C4087030

object_name: pervasive developmental disorder


subject: UMLS:C4087030

object_name: autism


subject: UMLS:C4087030

object_name: autism spectrum disorder


subject: UNII:7IK8Z952OK

subject_name: Plecanatide

object_name: Chronic idiopathic constipation


subject: CHEBI:23965

subject_name: estradiol

object_name: Malignant neoplasm of female breast


subject: CHEBI:23965

object_name: female breast carcinoma


subject: PUBCHEM.COMPOUND:343523

object_name: familial hyperinsulinism


subject: PUBCHEM.COMPOUND:343523

object_name: congenital isolated hyperinsulinism


subject: CHEBI:49166

subject_name: fluorodopa F 18


subject: CHEBI:49166


subject: MESH:C562323

object_name: schizophrenia


subject: CHEBI:7773

subject_name: Ondansetron

object_name: unspecified adult solid tumor, protocol specific


subject: PUBCHEM.COMPOUND:5487426

subject_name: Tiotropium bromide

object_name: asthma


subject: CHEBI:32230

subject_name: tiotropium bromide hydrate


subject: CHEMBL.COMPOUND:CHEMBL1182657

subject_name: tiotropium bromide


subject: UMLS:C5139926

object_name: influenza


subject: CHEBI:6931

subject_name: Midazolam

object_name: Helicobacter pylori infection


subject: PUBCHEM.COMPOUND:24956525

subject_name: Tyrosine kinase inhibitor

object_name: metastatic malignant neoplasm in the brain


subject: PUBCHEM.COMPOUND:24956525

object_name: HER2 positive breast carcinoma


subject: UMLS:C1268567

subject_name: Protein-tyrosine kinase inhibitor


subject: UMLS:C1268567


subject: PR:000017033

object_name: periodontitis


subject: UMLS:C0074512

subject_name: Signal Recognition Particle


subject: UMLS:C0003299

subject_name: Antiepileptic Agents

object_name: epilepsy


subject: CHEBI:3387

subject_name: Carbamazepine


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: pulmonary hypertension


subject: CHEBI:16480

object_name: Pulmonary Hypertension, CTCAE


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: pyoderma gangrenosum


subject: CHEBI:36791

subject_name: Escitalopram

object_name: brain injury


subject: CHEBI:36791

object_name: Suicidal ideation


subject: CHEBI:36791

object_name: Suicidal Ideation, CTCAE


subject: CHEBI:36791

object_name: chronic disease


subject: CHEBI:36791

object_name: Chronic Disease


subject: CHEBI:36791

object_name: Wounds and Injuries


subject: CHEBI:36791

object_name: alcohol-related disorders


subject: CHEBI:36791

object_name: substance-related disorder


subject: CHEBI:36791

object_name: mild neurocognitive disorder


subject: CHEBI:36791

object_name: mild cognitive impairment


subject: CHEBI:36791

object_name: outcomes general quality of life


subject: CHEBI:36791

object_name: Perceived quality of life


subject: CHEBI:36791

object_name: Good quality of life


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:4636

object_name: post-traumatic stress disorder


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:36796

subject_name: duloxetine


subject: CHEBI:36796


subject: CHEBI:36796


subject: CHEBI:36796


subject: CHEBI:36796


subject: CHEBI:36796


subject: CHEBI:36796


subject: CHEBI:36796


subject: CHEBI:36796


subject: CHEBI:36796


subject: CHEBI:36796


subject: CHEBI:36796


subject: CHEBI:5118

subject_name: Fluoxetine


subject: CHEBI:5118


subject: CHEBI:5118


subject: CHEBI:5118


subject: CHEBI:5118


subject: CHEBI:5118


subject: CHEBI:5118


subject: CHEBI:5118


subject: CHEBI:5118


subject: CHEBI:5118


subject: CHEBI:5118


subject: CHEBI:5118


subject: CHEBI:5118


subject: CHEBI:5118


subject: CHEBI:93274

subject_name: Fluvoxamine


subject: CHEBI:93274


subject: CHEBI:93274


subject: CHEBI:93274


subject: CHEBI:93274


subject: CHEBI:93274


subject: CHEBI:93274


subject: CHEBI:93274


subject: CHEBI:93274


subject: CHEBI:93274


subject: CHEBI:93274


subject: CHEBI:93274


subject: CHEBI:93274


subject: CHEBI:93274


subject: CHEBI:6950

subject_name: Mirtazapine


subject: CHEBI:6950


subject: CHEBI:6950


subject: CHEBI:6950


subject: CHEBI:6950


subject: CHEBI:6950


subject: CHEBI:6950


subject: CHEBI:6950


subject: CHEBI:6950


subject: CHEBI:6950


subject: CHEBI:6950


subject: CHEBI:6950


subject: CHEBI:6950


subject: CHEBI:6950


subject: CHEBI:7936

subject_name: Paroxetine


subject: CHEBI:7936


subject: CHEBI:7936


subject: CHEBI:7936


subject: CHEBI:7936


subject: CHEBI:7936


subject: CHEBI:7936


subject: CHEBI:7936


subject: CHEBI:7936


subject: CHEBI:7936


subject: CHEBI:7936


subject: CHEBI:7936


subject: CHEBI:7936


subject: CHEBI:8364

subject_name: Prazosin


subject: CHEBI:8364


subject: CHEBI:8364


subject: CHEBI:8364

object_name: Depressed mood


subject: CHEBI:8364

object_name: Cancer patients and suicide and depression


subject: CHEBI:8364

object_name: Depressed - symptom


subject: CHEBI:8364

object_name: Depression, CTCAE


subject: CHEBI:8364


subject: CHEBI:8364


subject: CHEBI:8364


subject: CHEBI:8364


subject: CHEBI:8364


subject: CHEBI:8364


subject: CHEBI:8364


subject: CHEBI:8364


subject: CHEBI:8364


subject: CHEBI:8364


subject: CHEBI:9123

subject_name: Sertraline

object_name: brain injury


subject: CHEBI:9123

object_name: Suicidal ideation


subject: CHEBI:9123

object_name: Suicidal Ideation, CTCAE


subject: CHEBI:9123

object_name: chronic disease


subject: CHEBI:9123

object_name: Chronic Disease


subject: CHEBI:9123

object_name: Wounds and Injuries


subject: CHEBI:9123

object_name: alcohol-related disorders


subject: CHEBI:9123

object_name: substance-related disorder


subject: CHEBI:9123

object_name: mild neurocognitive disorder


subject: CHEBI:9123

object_name: mild cognitive impairment


subject: CHEBI:9123

object_name: outcomes general quality of life


subject: CHEBI:9123

object_name: Perceived quality of life


subject: CHEBI:9123

object_name: Good quality of life


subject: CHEBI:9654

subject_name: Trazodone


subject: CHEBI:9654


subject: CHEBI:9654


subject: CHEBI:9654

object_name: post-traumatic stress disorder


subject: CHEBI:9654


subject: CHEBI:9654


subject: CHEBI:9654


subject: CHEBI:9654


subject: CHEBI:9654


subject: CHEBI:9654


subject: CHEBI:9654


subject: CHEBI:9654


subject: CHEBI:9943

subject_name: Venlafaxine


subject: CHEBI:9943


subject: CHEBI:9943


subject: CHEBI:9943


subject: CHEBI:9943


subject: CHEBI:9943


subject: CHEBI:9943


subject: CHEBI:9943


subject: CHEBI:9943


subject: CHEBI:9943


subject: CHEBI:9943


subject: CHEBI:9943


subject: CHEBI:9943


subject: CHEBI:9943


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Granulomatous sarcoid nephropathy


subject: CHEBI:33364

subject_name: Platinum

object_name: Small cell lung cancer limited stage


subject: CHEMBL.COMPOUND:CHEMBL1235478

subject_name: PLATINUM


subject: UMLS:C1171558

subject_name: Platinum metallicum, platinum, Homeopathic preparation


subject: UMLS:C1883555

subject_name: Whey Protein Isolate

object_name: hypertension


subject: UMLS:C1883555

object_name: Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:164933665

subject_name: enlicitide

object_name: hyperlipidemia


subject: PUBCHEM.COMPOUND:164933665

object_name: hyperlipoproteinemia


subject: PUBCHEM.COMPOUND:164933665

object_name: Hyperlipidemia, CTCAE


subject: PUBCHEM.COMPOUND:164933665

object_name: Serum lipids high (finding)


subject: UNII:R7EZ772VG2

subject_name: ENLICITIDE


subject: UNII:R7EZ772VG2


subject: UNII:R7EZ772VG2


subject: UNII:R7EZ772VG2


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Non-Hodgkin's lymphoma refractory


subject: UMLS:C5888788

subject_name: Cytarabine Liquid Injection


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:74705

subject_name: Met-Leu


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:231601

subject_name: trastuzumab

object_name: Stage IVA Major Salivary Gland Cancer AJCC v7


subject: CHEBI:231601

object_name: stage IVA salivary gland cancer


subject: CHEBI:231601

object_name: stage IVC salivary gland cancer


subject: CHEBI:231601

object_name: Stage IVC Major Salivary Gland Cancer AJCC v7


subject: CHEBI:231601

object_name: Stage IVB Major Salivary Gland Cancer AJCC v7


subject: CHEBI:231601

object_name: stage IVB salivary gland cancer


subject: CHEBI:231601

object_name: Adenocarcinoma of salivary gland


subject: CHEBI:231601

object_name: salivary gland acinic cell carcinoma


subject: CHEBI:231601

object_name: Salivary Gland High Grade Mucoepidermoid Carcinoma


subject: CHEBI:231601

object_name: Salivary Gland Poorly Differentiated Squamous Cell Carcinoma


subject: CHEBI:231601

object_name: Salivary Gland Poorly Differentiated Carcinoma


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: myeloid neoplasm


subject: CHEBI:2038

subject_name: Azacitidine


subject: UMLS:C1614968

subject_name: Sativex

object_name: Spasticity, CTCAE


subject: UMLS:C1614968

object_name: Spasticity


subject: CHEBI:72296

subject_name: Apixaban

object_name: Thromboembolism


subject: DRUGBANK:DB15862

subject_name: Inactivated SARS-Cov-2 Vaccine


subject: CHEBI:63610

subject_name: Misoprostol

object_name: abortion


subject: UNII:FA554TW3UP

object_name: rheumatoid arthritis


subject: DRUGBANK:DB05050


subject: UNII:61XQN688TW

object_name: kidney failure


subject: PUBCHEM.COMPOUND:11614352


subject: CHEBI:91398

subject_name: Tivantinib

object_name: neoplasm


subject: CHEBI:91398

object_name: Tumor Mass


subject: CHEBI:91398

object_name: cancer


subject: UMLS:C2607549

object_name: pulmonary embolism


subject: UMLS:C2607549

object_name: Deep venous thrombosis


subject: UMLS:C2607549

object_name: thrombophilia due to thrombin defect


subject: UMLS:C2607549

object_name: Venous thrombosis after immobility


subject: UMLS:C2607549


subject: UMLS:C2607549

object_name: venous thromboembolism


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban


subject: PUBCHEM.COMPOUND:11635624


subject: PUBCHEM.COMPOUND:11635624


subject: PUBCHEM.COMPOUND:11635624


subject: CHEBI:64816

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:145537

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:145537

object_name: acute myeloid leukemia


subject: UMLS:C3896859

subject_name: FLT3/CDK4/6 Inhibitor FLX925


subject: UMLS:C3896859


subject: CHEBI:31348

subject_name: Capecitabine

object_name: fallopian tube carcinoma


subject: CHEBI:31348

object_name: fallopian tube cancer


subject: CHEBI:31348

object_name: peritoneum cancer


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: CHEBI:4672


subject: UMLS:C5417926

object_name: migraine


subject: UMLS:C5417926

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:229643

subject_name: Zavegepant


subject: DRUGBANK:DB19304

object_name: Refractory acute myeloid leukemia


subject: DRUGBANK:DB19304

object_name: Myelodysplasia


subject: DRUGBANK:DB19304


subject: DRUGBANK:DB19304


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: Sentinel node (disorder)


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:T42P99266K

subject_name: METHYLENE BLUE


subject: UNII:T42P99266K

object_name: Childhood Breast Carcinoma


subject: UNII:T42P99266K

object_name: breast carcinoma


subject: UNII:T42P99266K

object_name: breast cancer


subject: CHEBI:43830

subject_name: Methylthioninium


subject: CHEBI:43830


subject: CHEBI:43830


subject: CHEBI:43830


subject: CHEBI:136003

subject_name: Levomethadone

object_name: opiate dependence


subject: CHEBI:50731

subject_name: morphine sulfate pentahydrate


subject: CHEBI:24757

subject_name: Hypochlorite

object_name: dental pulp disorder


subject: CHEBI:24757

object_name: Pulp Mummification


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: systemic sclerosis


subject: CHEBI:4026


subject: CHEBI:4027


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:125354

subject_name: Plerixafor


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Rare Diseases


subject: UNII:4521NR0J09

object_name: Sepsis


subject: UNII:4521NR0J09

object_name: Sepsis, CTCAE


subject: PUBCHEM.COMPOUND:21874242

subject_name: Vinflunine

object_name: Embolism, Tumor


subject: PUBCHEM.COMPOUND:21874242

object_name: Neoplasm Metastasis


subject: PUBCHEM.COMPOUND:21874242

object_name: Metastatic Lesion


subject: UMLS:C2987407

object_name: triple-negative breast carcinoma


subject: UMLS:C2987407

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:90ZX3Q3FR7

subject_name: Risankizumab

object_name: ulcerative colitis


subject: UMLS:C4078397


subject: PUBCHEM.COMPOUND:21634109

subject_name: Lacosamide

object_name: focal epilepsy


subject: CHEBI:139072

object_name: Cannabis use disorder, severe


subject: CHEBI:139072

object_name: Cannabis use disorder, moderate


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: UMLS:C5417921


subject: UMLS:C5417921

object_name: inflammatory bowel disease 1


subject: UMLS:C5417921

object_name: Crohn disease


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Metastatic Thyroid Gland Carcinoma


subject: CHEBI:85994

object_name: Unresectable Thyroid Gland Carcinoma


subject: CHEBI:85994

object_name: Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8


subject: CHEBI:85994

object_name: Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8


subject: CHEBI:85994

object_name: thyroid gland squamous cell carcinoma


subject: CHEBI:85994

object_name: poorly differentiated thyroid gland carcinoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Pancreas carcinoma resectable


subject: PUBCHEM.COMPOUND:14907381

object_name: pancreatic adenocarcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IA Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IA Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:14907381

object_name: stage IB pancreatic cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IB Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IB Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage III Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Pancreatic carcinoma stage III


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:14907381

object_name: stage IIB pancreatic cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIB Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIB Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIA Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIA Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:14907381

object_name: stage IIA pancreatic cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: undifferentiated pancreatic carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Poorly Differentiated Malignant Neoplasm


subject: CHEBI:46345

subject_name: Fluorouracil

object_name: Pancreas carcinoma resectable


subject: CHEBI:46345

object_name: pancreatic adenocarcinoma


subject: CHEBI:46345

object_name: Stage IA Pancreatic Cancer AJCC v8


subject: CHEBI:46345

object_name: Stage IA Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:46345

object_name: stage IB pancreatic cancer


subject: CHEBI:46345

object_name: Stage IB Pancreatic Cancer AJCC v8


subject: CHEBI:46345

object_name: Stage IB Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:46345

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:46345

object_name: Pancreatic carcinoma stage III


subject: CHEBI:46345

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:46345

object_name: stage IIB pancreatic cancer


subject: CHEBI:46345

object_name: Stage IIB Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:46345

object_name: Stage IIB Pancreatic Cancer AJCC v8


subject: CHEBI:46345

object_name: Stage IIA Pancreatic Cancer AJCC v8


subject: CHEBI:46345

object_name: Stage IIA Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:46345

object_name: stage IIA pancreatic cancer


subject: CHEBI:46345

object_name: undifferentiated pancreatic carcinoma


subject: CHEBI:46345

object_name: Poorly Differentiated Malignant Neoplasm


subject: CHEBI:90881

subject_name: Camptosar

object_name: Pancreas carcinoma resectable


subject: CHEBI:90881

object_name: pancreatic adenocarcinoma


subject: CHEBI:90881

object_name: Stage IA Pancreatic Cancer AJCC v8


subject: CHEBI:90881

object_name: Stage IA Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:90881

object_name: stage IB pancreatic cancer


subject: CHEBI:90881

object_name: Stage IB Pancreatic Cancer AJCC v8


subject: CHEBI:90881

object_name: Stage IB Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:90881

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:90881

object_name: Pancreatic carcinoma stage III


subject: CHEBI:90881

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:90881

object_name: stage IIB pancreatic cancer


subject: CHEBI:90881

object_name: Stage IIB Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:90881

object_name: Stage IIB Pancreatic Cancer AJCC v8


subject: CHEBI:90881

object_name: Stage IIA Pancreatic Cancer AJCC v8


subject: CHEBI:90881

object_name: Stage IIA Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:90881

object_name: stage IIA pancreatic cancer


subject: CHEBI:90881

object_name: undifferentiated pancreatic carcinoma


subject: CHEBI:90881

object_name: Poorly Differentiated Malignant Neoplasm


subject: CHEBI:8988

object_name: Pancreas carcinoma resectable


subject: CHEBI:8988

object_name: Stage IA Pancreatic Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage IA Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:8988

object_name: stage IB pancreatic cancer


subject: CHEBI:8988

object_name: Stage IB Pancreatic Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage IB Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:8988

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:8988

object_name: Pancreatic carcinoma stage III


subject: CHEBI:8988

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:8988

object_name: stage IIB pancreatic cancer


subject: CHEBI:8988

object_name: Stage IIB Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:8988

object_name: Stage IIB Pancreatic Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage IIA Pancreatic Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage IIA Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:8988

object_name: stage IIA pancreatic cancer


subject: CHEBI:8988

object_name: undifferentiated pancreatic carcinoma


subject: CHEBI:8988

object_name: Poorly Differentiated Malignant Neoplasm


subject: CHEBI:80630

subject_name: Irinotecan

object_name: Pancreas carcinoma resectable


subject: CHEBI:80630

object_name: Stage IA Pancreatic Cancer AJCC v8


subject: CHEBI:80630

object_name: Stage IA Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:80630

object_name: stage IB pancreatic cancer


subject: CHEBI:80630

object_name: Stage IB Pancreatic Cancer AJCC v8


subject: CHEBI:80630

object_name: Stage IB Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:80630

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:80630

object_name: Pancreatic carcinoma stage III


subject: CHEBI:80630

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:80630

object_name: stage IIB pancreatic cancer


subject: CHEBI:80630

object_name: Stage IIB Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:80630

object_name: Stage IIB Pancreatic Cancer AJCC v8


subject: CHEBI:80630

object_name: Stage IIA Pancreatic Cancer AJCC v8


subject: CHEBI:80630

object_name: Stage IIA Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:80630

object_name: stage IIA pancreatic cancer


subject: CHEBI:80630

object_name: undifferentiated pancreatic carcinoma


subject: CHEBI:80630

object_name: Poorly Differentiated Malignant Neoplasm


subject: CHEBI:15640

subject_name: Leucovorin

object_name: Pancreas carcinoma resectable


subject: CHEBI:15640

object_name: pancreatic adenocarcinoma


subject: CHEBI:15640

object_name: Stage IA Pancreatic Cancer AJCC v8


subject: CHEBI:15640

object_name: Stage IA Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:15640

object_name: stage IB pancreatic cancer


subject: CHEBI:15640

object_name: Stage IB Pancreatic Cancer AJCC v8


subject: CHEBI:15640

object_name: Stage IB Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:15640

object_name: Stage III Pancreatic Cancer AJCC v8